Agilon Health (AGL) Cash & Current Investments (2020 - 2026)

Agilon Health (AGL) has 7 years of Cash & Current Investments data on file, last reported at $231.4 million in Q1 2026.

• Quarterly Cash & Current Investments fell 36.96% year-over-year to $231.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $231.4 million (down 36.96% YoY) and the FY2025 annual result came in at $285.1 million, down 28.71% from the prior year.
• Cash & Current Investments retreated to $231.4 million in Q1 2026, from $285.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $1.0 billion in Q1 2022 to a low of $231.4 million in Q1 2026.
• A 5-year average of $552.7 million and a median of $419.1 million in 2024 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2022 — Cash & Current Investments surged 870.43% — and 2024, when it plunged 48.69%.
• Tracing AGL's Cash & Current Investments over 5 years: stood at $877.2 million in 2022, then plunged by 44.33% to $488.3 million in 2023, then slipped by 18.1% to $400.0 million in 2024, then decreased by 28.71% to $285.1 million in 2025, then slipped by 18.84% to $231.4 million in 2026.
• The last three Cash & Current Investments figures came in at $231.4 million (Q1 2026), $285.1 million (Q4 2025), and $310.9 million (Q3 2025), per Business Quant data.